Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, Priscilla Kinderman, Xiaoying Han, Anna Halling Folkmar Rahimic, Alena Kress, Madalina E. Carter-Timofte, Emilia Holm, Demi van der Horst, Christoph F. Kollmann, Zhenlong Liu, Chen Wang, Huy‐Dung Hoang, Elina Kovalenko, Maria Chrysopoulou, Krishna Sundar Twayana, Rasmus N. Ottosen, Esben B. Svenningsen, Fabio Begnini, Anders E. Kiib, Florian E. H. Kromm, Hauke J. Weiss, Daniele Di Carlo, Michela Muscolini, Maureen Higgins, Mirte van der Heijden, Rozanne Arulanandam, Angelina Bardoul, Tong Tong, Attila Ozsvár, Wen‐Hsien Hou, Vivien R. Schack, Christian K. Holm, Yunan Zheng, Melanie C. Ruzek, Joanna Kalucka, Laureano de la Vega, Walid A. M. Elgaher, Anders Rosendal Korshoej, Rongtuan Lin, John Hiscott, Thomas B. Poulsen, Luke O'neill, Dominic G. Roy, Markus M. Rinschen, Nadine van Montfoort, Jean‐Simon Diallo, Henner F. Farin, Tommy Alain, David Olagnier (2024). Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways. , 15 (1), DOI: https://doi.org/10.1038/s41467-024-55044-w.
